Hubbry Logo
Andrew FireAndrew FireMain
Open search
Andrew Fire
Community hub
Andrew Fire
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Andrew Fire
Andrew Fire
from Wikipedia

Andrew Zachary Fire (born April 27, 1959) is an American biologist and professor of pathology and of genetics at the Stanford University School of Medicine. He was awarded the 2006 Nobel Prize in Physiology or Medicine, along with Craig C. Mello, for the discovery of RNA interference (RNAi). This research was conducted at the Carnegie Institution of Washington and published in 1998.

Key Information

Biography

[edit]

Andrew Z Fire was born in Palo Alto, California and raised in Sunnyvale, California[1] in a Jewish[2] family. He graduated from Fremont High School. He attended the University of California, Berkeley for his undergraduate degree, where he received a B.A. in mathematics in 1978 at the age of 19.[3] He then proceeded to the Massachusetts Institute of Technology, where he received a Ph.D. in biology in 1983 under the mentorship of Nobel laureate geneticist Phillip Sharp.

Fire moved to Cambridge, England, as a Helen Hay Whitney Postdoctoral Fellow. He became a member of the MRC Laboratory of Molecular Biology group headed by Nobel laureate biologist Sydney Brenner.

From 1986 to 2003, Fire was a staff member of the Carnegie Institution of Washington’s Department of Embryology in Baltimore, Maryland. The initial work on double stranded RNA as a trigger of gene silencing was published while Fire and his group were at the Carnegie Labs.[1] Fire became an adjunct professor in the Department of Biology at Johns Hopkins University in 1989 and joined the Stanford faculty in 2003. Throughout his career, Fire has been supported by research grants from the U.S. National Institutes of Health.

Fire is a member of the National Academy of Sciences and the American Academy of Arts and Sciences. He also serves on the Board of Scientific Counselors and the National Center for Biotechnology, National Institutes of Health.

Nobel Prize

[edit]

In 2006, Fire and Craig Mello shared the Nobel Prize in Physiology or Medicine for work first published in 1998 in the journal Nature.[4] Fire and Mello, along with colleagues SiQun Xu, Mary Montgomery, Stephen Kostas, and Sam Driver, reported that tiny snippets of double-stranded RNA (dsRNA) effectively shut down specific genes, driving the destruction of messenger RNA (mRNA) with sequences matching the dsRNA. As a result, the mRNA cannot be translated into protein. Fire and Mello found that dsRNA was much more effective in gene silencing than the previously described method of RNA interference with single-stranded RNA. Because only small numbers of dsRNA molecules were required for the observed effect, Fire and Mello proposed that a catalytic process was involved. This hypothesis was confirmed by subsequent research.

The Nobel Prize citation, issued by Sweden's Karolinska Institute, said: "This year's Nobel Laureates have discovered a fundamental mechanism for controlling the flow of genetic information." The British Broadcasting Corporation (BBC) quoted Nick Hastie, director of the Medical Research Council's Human Genetics Unit, on the scope and implications of the research:

It is very unusual for a piece of work to completely revolutionise the whole way we think about biological processes and regulation, but this has opened up a whole new field in biology.[5]

Awards and honors

[edit]

Fire has received the following awards and honors:
(By chronological year of award [6])

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia
from Grokipedia
Andrew Zachary Fire (born April 27, 1959) is an American biologist renowned for his pioneering work in , particularly the discovery of (RNAi), a mechanism by which double-stranded molecules can silence specific genes, revolutionizing genetic research and earning him the 2006 in Physiology or Medicine shared with Craig C. Mello. Born in Stanford University Hospital in Santa Clara County, California, Fire grew up primarily in Sunnyvale until age 16, attending local public schools including Hollenbeck Elementary, Mango Junior High, and Fremont High School, where he developed a keen interest in science through participation in science fairs and reading . He earned an A.B. in mathematics from the , in 1978, followed by a Ph.D. in biology from the in 1983, with a thesis on in vitro transcription studies of adenovirus. Fire's career began with postdoctoral training at the MRC Laboratory of Molecular Biology in Cambridge, UK (1983–1986), after which he joined the Carnegie Institution of Washington in Baltimore as a staff associate (1986–1989), becoming a full staff member in 1989 and serving until 2003, while also holding an adjunct professorship in the Biology Department at Johns Hopkins University. In 2003, he moved to Stanford University School of Medicine as Professor of Pathology and Genetics, and he currently holds the George D. Smith Professorship in Molecular and Genetic Medicine. His research in the Fire Lab focuses on non-chromosomal agents of genetic change and cellular responses to genetic perturbations, building on RNAi to explore gene regulation in model organisms like Caenorhabditis elegans. The 1998 discovery of RNAi, demonstrating that double-stranded RNA triggers potent and specific gene silencing, has had profound impacts on fields from developmental biology to therapeutic applications, including potential treatments for genetic diseases and cancers.

Early Life and Education

Early Life

Andrew Fire was born on April 27, 1959, at Stanford University Hospital in . He spent most of his childhood in nearby , where he attended local public schools, including Hollenbeck Elementary School from 1964 to 1970, Mango Junior High School from 1970 to 1972, and Fremont High School from 1972 to 1975, graduating at the age of 15. Raised in a Jewish family, Fire grew up in a household that valued intellectual pursuits, with his father working as a Silicon Valley engineer. From an early age, Fire showed a strong interest in and , nurtured by his family's supportive environment that encouraged and for engineering and scientific endeavors. This formative background in Sunnyvale's burgeoning tech community helped shape his early passion for these fields. He later transitioned to undergraduate studies at the .

Education

Fire earned a degree in mathematics from the , in 1978, after enrolling in the fall of 1975. He then pursued graduate studies at the (MIT), where he received a Ph.D. in biology in 1983 under the supervision of Phillip A. Sharp. His doctoral research focused on techniques, particularly transcription studies of the adenovirus genome using whole cell extracts from cells and reconstituted systems with purified . This work explored during the viral , including early-to-late promoter shifts, dinucleotide priming for initiation, and RNA processing events such as capping and heterogeneity in 5' termini, providing insights into mechanisms.

Professional Career

Postdoctoral Research

Following the completion of his Ph.D. in from the Massachusetts Institute of Technology in 1983, Andrew Fire served as a Postdoctoral Fellow at the Medical Research Council Laboratory of in , , from 1983 to 1986. During this fellowship, Fire worked under and Alan Coulson, focusing on (C. elegans) genetics and genome mapping. His efforts contributed to early advances in understanding the nematode's genetic structure, including the development of techniques for DNA integration and manipulation in the worm's genome. This period was instrumental in building Fire's expertise in C. elegans as a model system, where he honed skills in worm through experimental approaches like for gene transfer and analysis of genetic transformations. He also gained proficiency in RNA-related techniques, such as antisense RNA methods for probing gene function, laying foundational knowledge for subsequent research in .

Career at Carnegie Institution

In 1986, Andrew Fire joined the Department of at the Carnegie Institution of Washington in , , initially as a staff associate, where he secured funding from the to investigate gene regulation during early development in the Caenorhabditis elegans. By 1989, he was promoted to a regular staff member position, allowing him to establish an independent laboratory dedicated to developmental genetics, with a primary focus on advancing DNA transformation techniques and assays for in C. elegans. Fire maintained this role at Carnegie until 2003, during which his lab contributed to foundational studies in genetic manipulation and regulatory mechanisms in model organisms. In 1989, Fire also received an adjunct faculty appointment in the Department of Biology at the Johns Hopkins University School of Medicine, a position he held concurrently with his Carnegie duties to facilitate teaching and interdisciplinary collaborations. This affiliation enabled him to mentor graduate students and contribute to academic programs at Johns Hopkins while leading his research group at the nearby Carnegie facility. Throughout his tenure at Carnegie, Fire built a collaborative research environment, mentoring a team of postdocs, technicians, and students—such as Jamie Fleenor, Steve Kostas, and Mary Montgomery—who supported investigations into genetic pathways. He also engaged in key external collaborations, including early joint efforts with on genetic tools in C. elegans, which advanced the lab's work in .

Faculty at Stanford University

In 2003, Andrew Fire joined the as Professor of Pathology and Genetics, marking his transition from the Carnegie Institution of Washington where he had conducted much of his pioneering work on . He was later appointed the George D. Smith Professor of Molecular and Genetic Medicine, a distinguished endowed chair that recognizes his contributions to the field. Upon arriving at Stanford, Fire established his laboratory, known as the Fire Lab, which focuses on the mechanisms by which cells and organisms respond to genetic change, exploring non-chromosomal agents of genetic constancy and variation using model systems like and other organisms. This research builds on his expertise in gene regulation while integrating Stanford's resources in and to investigate cellular recognition of self versus nonself genetic elements. Fire continues to hold his professorial positions in the Departments of Pathology and Genetics, contributing to the molecular biology community through these roles, which encompass teaching graduate and postdoctoral trainees in genetics and related disciplines as well as participating in departmental governance and program development. His ongoing involvement supports Stanford's Biosciences PhD program and fosters interdisciplinary collaborations in molecular and genetic medicine.

Scientific Contributions

Discovery of RNA Interference

In the mid-1990s, Andrew Fire, then at the Carnegie Institution for Science's Department of Embryology in , began collaborating with Craig C. Mello, a fellow researcher there, to explore methods for manipulating in the nematode , building on Fire's prior experience with the organism during his postdoctoral training. Their work focused on enhancing the efficiency of antisense RNA approaches, which had previously shown limited success in silencing specific genes. The pivotal experiments involved microinjecting RNA into the gonads of adult C. elegans hermaphrodites to target the unc-22 gene, a myosin-associated protein essential for normal muscle function whose disruption causes a characteristic twitching phenotype. Single-stranded sense RNA or antisense RNA injections produced only weak or inconsistent silencing effects, often requiring high concentrations and affecting few progeny. In contrast, injecting double-stranded RNA (dsRNA)—either as a direct dsRNA preparation or as a mixture of complementary sense and antisense strands—triggered robust, sequence-specific gene silencing, with nearly all progeny exhibiting the twitching phenotype even at low doses equivalent to roughly one dsRNA molecule per affected cell. Similar results were observed when targeting other genes, such as mex-3, confirming the specificity and potency of dsRNA-mediated interference. These effects were heritable, persisting across at least one generation of offspring, and spread systemically within the organism, suggesting an amplification or catalytic process. Fire and Mello's findings demonstrated that dsRNA was orders of magnitude more effective than single-stranded RNA for eliciting RNA interference (RNAi), a term they used to describe this potent form of post-transcriptional gene silencing. The interference was highly specific to the targeted sequence, with mismatches reducing or abolishing the effect, and it correlated with the degradation of the corresponding endogenous mRNA, as verified by in situ hybridization. Unlike traditional antisense methods, RNAi required minimal RNA input and produced uniform outcomes, revolutionizing functional genomics in C. elegans. These observations were detailed in their seminal paper published in Nature on February 19, 1998, titled "Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans." Subsequent mechanistic studies stemming from this discovery revealed that dsRNA is diced by the RNase III family enzyme into 21- to 23-nucleotide small interfering RNAs (siRNAs), which are loaded into the (RISC). Within RISC, the siRNA guides the complex to complementary mRNA targets, where the protein cleaves the mRNA, preventing and leading to its degradation; this process explains the catalytic nature and amplification observed in the original experiments. In C. elegans, additional pathway components like the protein RDE-1 facilitate siRNA incorporation into RISC, ensuring efficient silencing.

Research on Gene Regulation

Following the discovery of RNA interference (RNAi), Andrew Fire's research extended its applications as a powerful tool for , enabling systematic studies in diverse organisms beyond . In , RNAi protocols adapted from Fire's laboratory vectors facilitated high-throughput screens to dissect gene functions in development and signaling pathways, revealing essential roles for hundreds of genes in embryonic patterning and . Similarly, in mammalian cells, Fire's contributions to siRNA design principles supported functional analyses of gene networks, such as those involved in cancer progression, by allowing precise silencing without the toxicity of long dsRNA. These extensions underscored RNAi conservation across metazoans, with orthologous machinery enabling efficient gene disruption in plants, trypanosomes, and vertebrates for genome-wide functional annotation. Fire's investigations further illuminated the role of microRNAs (miRNAs) in developmental gene regulation, linking the RNAi pathway to endogenous small RNA control of timing and differentiation in C. elegans. A seminal 2001 study by Lee et al. demonstrated that core RNAi components, including the protein RDE-1 and the RNase III enzyme DCR-1, are required for the biogenesis and function of miRNAs like lin-4 and let-7, which temporally repress target mRNAs to orchestrate larval-to-adult transitions. This work revealed that miRNAs operate through partial complementarity to inhibit translation rather than degrade mRNA, providing mechanistic insights into how RNAi-related pathways fine-tune during multicellular development. By integrating genetic screens with biochemical assays, Fire's team established miRNAs as widespread regulators, influencing over 30% of protein-coding genes in animals and paving the way for understanding their dysregulation in diseases like . Fire also probed RNA-mediated chromatin modifications and epigenetic silencing, showing how RNAi induces heritable gene repression through nuclear targeting in C. elegans. His laboratory demonstrated that dsRNA triggers propagate silencing signals across generations via , involving modifications and DNA methylation-like processes that maintain at target loci even after the initial trigger dissipates. For instance, systemic RNAi via the SID-1 transporter spreads nuclear effectors to silence transgenes epigenetically, preventing reactivation in progeny and highlighting RNA's role in transgenerational memory. These findings connected cytoplasmic RNAi to nuclear epigenetics, where small RNAs guide complexes to nascent transcripts, recruiting factors for stable repression. Key publications from the by Fire's group addressed RNAi specificity and off-target effects, refining the technology for reliable gene regulation studies. In Parrish et al. (2000), they mapped the functional of dsRNA triggers, showing that only 21-nucleotide siRNAs with precise 5' end selection mediate potent silencing, while mismatches reduce efficiency by over 100-fold. Later, Sijen et al. (2001) explored transitive RNAi, revealing how secondary siRNAs amplify signals but introduce unintended targets, complicating specificity . Fire's 2007 analysis with Pak further delineated primary versus secondary effectors, emphasizing sequence-dependent off-target risks in mammals, where partial homologies (as few as 7 ) can deregulate non-cognate genes, informing siRNA design guidelines to minimize artifacts in .

Ongoing Work in RNA Biology

At , Andrew Fire's laboratory investigates the mechanisms by which cells and organisms respond to genetic changes, with a particular emphasis on -mediated processes that maintain genetic constancy or drive variation. This work explores how cellular systems distinguish self from nonself genetic elements, including DNA and RNA agents from the genome, virome, and mobilome, using model organisms like as well as non-model systems to uncover novel pathways in RNA biology. Recent studies from Fire's group have centered on "opportunistic RNAs," a class of mobile, heritable elements that colonize microbial communities and influence genetic dynamics. For instance, research published in 2024 identified "obelisks," viroid-like structures in human gut bacteria such as sanguinis, which replicate independently and may facilitate by integrating into bacterial mobilomes. These findings highlight "acquisitive genomes," where opportunistic RNAs contribute to the acquisition of foreign genetic material, enabling adaptive responses in dynamic environments like microbiomes. In May 2025, Fire delivered a seminar titled "Opportunistic RNAs and Acquisitive Genomes" at the (UTMB), discussing how these RNA elements and horizontal transfer mechanisms shape genomic plasticity across species. In a November 2025 article on the expansion of Brown's Giuliani RNA Center with new donation and NIH grant, Nobel laureate noted, “It’s really exciting right now in RNA biology because it seems like everyday we’re learning more about the incredible intricacies and complexities in which is playing a major role in controlling (genetic) information and human health.” Fire participated in the 2025 Nobel Prize Dialogue in , where he contributed to discussions on the enduring impacts of (RNAi) on gene regulation and therapeutic applications, building on its foundational role in modern .

Awards and Honors

Nobel Prize

On October 2, 2006, Andrew Fire was awarded the in Physiology or Medicine, shared jointly with of the University of Massachusetts Medical School. The Nobel Assembly at the recognized their independent but complementary work demonstrating that double-stranded RNA can trigger specific in organisms. The official citation stated: "for their discovery of RNA interference – gene silencing by double-stranded RNA." This breakthrough, first detailed in Fire's 1998 paper in Nature, revealed a previously unknown mechanism of gene regulation conserved across species. The Nobel ceremony took place in Stockholm, Sweden. On December 8, 2006, Fire delivered his Nobel Lecture titled "Gene Silencing by Double Stranded RNA" at the Karolinska Institutet, where he elaborated on the molecular mechanisms of RNA interference, including how double-stranded RNA guides the degradation of target messenger RNA to silence genes. The award banquet followed on December 10 at Stockholm City Hall. The elevated the recognition of as a fundamental , accelerating its adoption in for research tools and potential therapeutics. This acknowledgment spurred widespread application of RNAi techniques in labs worldwide, transforming approaches to studying gene function and disease.

Other Awards and Memberships

In addition to his Nobel Prize, Andrew Fire has received numerous prestigious awards recognizing his contributions to RNA biology and gene regulation. In 2003, he shared the National Academy of Sciences (NAS) Award in Molecular Biology with Craig C. Mello for inventing methods to inactivate genes through RNA interference and elucidating their mechanisms. That same year, Fire and Mello were co-recipients of the Wiley Prize in from the Wiley Foundation for their pioneering work on RNA interference. In 2004, Fire received the Heineken Prize for Biochemistry and Biophysics from the Royal Netherlands Academy of Arts and Sciences, honoring his research on nucleic acids and . Fire's accolades continued in 2005 with the , shared with Mello, for the discovery of and its transformative impact on studies. Also in 2005, he shared the Lewis S. Rosenstiel Award for Distinguished Work in Basic Medical Research from with Victor Ambros and Gary Ruvkun, acknowledging their collective advancements in understanding small RNAs in gene regulation. In 2005, Fire received the Massry Prize from the Keck School of Medicine for his contributions to understanding . Earlier, in 2002, Fire was awarded the Genetics Society of America Medal for his mid-career contributions to genetics, particularly in and function. He also received the Meyenburg Prize from the German Cancer Research Center that year for his innovative approaches to gene regulation. In 2006, Fire shared the and Ludwig Darmstaedter Prize with Craig C. Mello for their discovery of . Fire is an elected member of the (2004), where he serves in the sections on and Cellular and . He was also elected a Fellow of the American Academy of Arts and Sciences in 2004, recognizing his distinguished achievements in biological sciences.

References

Add your contribution
Related Hubs
User Avatar
No comments yet.